Gonzalez, H., Hagerling, C. & Werb, Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 32, 1267–1284 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J. & Schreiber, R. D. Cancer immunoediting: from immunosurveillance to tumor escape. Nat. Immunol. 3, 991–998 (2002).

Article  CAS  PubMed  Google Scholar 

Dunn, G. P., Old, L. J. & Schreiber, R. D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137–148 (2004).

Article  CAS  PubMed  Google Scholar 

Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331, 1565–1570 (2011).

Article  CAS  PubMed  Google Scholar 

O’Donnell, J. S., Teng, M. W. L. & Smyth, M. J. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol. 16, 151–167 (2019).

Article  PubMed  Google Scholar 

Matsushita, H. et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 482, 400–404 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

DuPage, M. et al. Expression of tumour-specific antigens underlies cancer immunoediting. Nature 482, 405–409 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chaplin, D. D. Overview of the immune response. J. Allergy Clin. Immunol. 125, S3–S23 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Chiappinelli, K. B. et al. Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses. Cell 162, 974–986 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tan, Y. et al. Somatic epigenetic silencing of RIPK3 inactivates necroptosis and contributes to chemoresistance in malignant mesothelioma. Clin. Cancer Res. 27, 1200–1213 (2021).

Article  CAS  PubMed  Google Scholar 

Turpin, J. et al. The ErbB2DeltaEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment. Oncogene 35, 6053–6064 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang, Y. et al. Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown. Proc. Natl Acad. Sci. USA 118, e2022830118 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e29 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cristea, S. & Polyak, K. Dissecting the mammary gland one cell at a time. Nat. Commun. 9, 2473 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Saeki, K. et al. Mammary cell gene expression atlas links epithelial cell remodeling events to breast carcinogenesis. Commun. Biol. 4, 660 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gulati, G. S. et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science 367, 405–411 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Samarajiwa, S. A., Forster, S., Auchettl, K. & Hertzog, P. J. INTERFEROME: the database of interferon regulated genes. Nucleic Acids Res. 37, D852–D857 (2009).

Article  CAS  PubMed  Google Scholar 

Zhang, Z. et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature 579, 415–420 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Snyder, A. G. et al. Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity. Sci. Immunol. 4, eaaw2004 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Virassamy, B. et al. Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer. Cancer Cell 41, 585–601.e8 (2023).

Article  CAS  PubMed  Google Scholar 

Chou, C. et al. Programme of self-reactive innate-like T cell-mediated cancer immunity. Nature 605, 139–145 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).

Article  PubMed  Google Scholar 

Ganesan, A.-P. et al. Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer. Nat. Immunol. 18, 940–950 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schenkel, J. M. et al. Resident memory CD8 T cells trigger protective innate and adaptive immune responses. Science 346, 98–101 (2014).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miller, B. C. et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326–336 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vodnala, S. K. et al. T cell stemness and dysfunction in tumors are triggered by a common mechanism. Science 363, eaau0135 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morrish, E. & Ruland, J. Cytotoxic FCER1G+ innate-like T cells: new potential for tumour immunotherapy. Signal Transduct. Target. Ther. 7, 204 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gore, Y. et al. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem. 283, 2784–2792 (2008).

Article  CAS  PubMed  Google Scholar 

Cashen, A. F., Shah, A. K., Todt, L., Fisher, N. & DiPersio, J. Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Cancer Chemother. Pharmacol. 61, 759–766 (2008).